State Street’s BioMarin Pharmaceuticals BMRN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$486M Buy
8,847,751
+384,661
+5% +$21.1M 0.02% 553
2025
Q1
$598M Sell
8,463,090
-649,185
-7% -$45.9M 0.02% 495
2024
Q4
$599M Buy
9,112,275
+289,161
+3% +$19M 0.02% 501
2024
Q3
$620M Sell
8,823,114
-812,906
-8% -$57.1M 0.03% 497
2024
Q2
$793M Buy
9,636,020
+2,740,805
+40% +$226M 0.03% 402
2024
Q1
$602M Buy
6,895,215
+164,700
+2% +$14.4M 0.03% 488
2023
Q4
$649M Buy
6,730,515
+271,786
+4% +$26.2M 0.03% 462
2023
Q3
$571M Buy
6,458,729
+505,045
+8% +$44.7M 0.03% 449
2023
Q2
$516M Sell
5,953,684
-112,634
-2% -$9.76M 0.03% 500
2023
Q1
$590M Buy
6,066,318
+677,474
+13% +$65.9M 0.03% 452
2022
Q4
$558M Buy
5,388,844
+110,406
+2% +$11.4M 0.03% 452
2022
Q3
$447M Sell
5,278,438
-117,928
-2% -$10M 0.03% 492
2022
Q2
$447M Buy
5,396,366
+15,973
+0.3% +$1.32M 0.03% 506
2022
Q1
$415M Buy
5,380,393
+64,300
+1% +$4.96M 0.02% 587
2021
Q4
$470M Buy
5,316,093
+278,628
+6% +$24.6M 0.02% 551
2021
Q3
$389M Buy
5,037,465
+130,408
+3% +$10.1M 0.02% 586
2021
Q2
$409M Buy
4,907,057
+232,655
+5% +$19.4M 0.02% 592
2021
Q1
$353M Sell
4,674,402
-285,377
-6% -$21.5M 0.02% 603
2020
Q4
$435M Buy
4,959,779
+67,978
+1% +$5.96M 0.03% 518
2020
Q3
$372M Sell
4,891,801
-254,700
-5% -$19.4M 0.03% 502
2020
Q2
$635M Sell
5,146,501
-393,044
-7% -$48.5M 0.05% 364
2020
Q1
$468M Buy
5,539,545
+628,230
+13% +$53.1M 0.04% 382
2019
Q4
$415M Buy
4,911,315
+35,533
+0.7% +$3M 0.03% 510
2019
Q3
$329M Buy
4,875,782
+186,442
+4% +$12.6M 0.02% 546
2019
Q2
$402M Buy
4,689,340
+53,188
+1% +$4.56M 0.03% 500
2019
Q1
$412M Buy
4,636,152
+738,589
+19% +$65.6M 0.03% 478
2018
Q4
$332M Sell
3,897,563
-38,806
-1% -$3.3M 0.03% 486
2018
Q3
$382M Buy
3,936,369
+133,232
+4% +$12.9M 0.03% 501
2018
Q2
$358M Sell
3,803,137
-220,199
-5% -$20.7M 0.03% 510
2018
Q1
$326M Buy
4,023,336
+28,761
+0.7% +$2.33M 0.03% 524
2017
Q4
$356M Sell
3,994,575
-19,693
-0.5% -$1.76M 0.03% 515
2017
Q3
$374M Buy
4,014,268
+118,018
+3% +$11M 0.03% 478
2017
Q2
$354M Sell
3,896,250
-105,279
-3% -$9.56M 0.03% 490
2017
Q1
$351M Buy
4,001,529
+258,417
+7% +$22.7M 0.03% 492
2016
Q4
$310M Buy
3,743,112
+108,065
+3% +$8.95M 0.03% 509
2016
Q3
$336M Buy
3,635,047
+286,010
+9% +$26.5M 0.03% 484
2016
Q2
$261M Buy
3,349,037
+62,294
+2% +$4.85M 0.03% 531
2016
Q1
$271M Buy
3,286,743
+175,733
+6% +$14.5M 0.03% 522
2015
Q4
$326M Buy
3,111,010
+4,083
+0.1% +$428K 0.04% 461
2015
Q3
$327M Buy
3,106,927
+272,434
+10% +$28.7M 0.04% 437
2015
Q2
$388M Buy
2,834,493
+20,329
+0.7% +$2.78M 0.04% 416
2015
Q1
$351M Buy
2,814,164
+158,546
+6% +$19.8M 0.04% 456
2014
Q4
$240M Sell
2,655,618
-1,302,679
-33% -$118M 0.02% 555
2014
Q3
$286M Sell
3,958,297
-359,784
-8% -$26M 0.03% 492
2014
Q2
$269M Buy
4,318,081
+426,323
+11% +$26.5M 0.03% 512
2014
Q1
$265M Buy
3,891,758
+706,677
+22% +$48.2M 0.03% 500
2013
Q4
$224M Buy
3,185,081
+736,150
+30% +$51.7M 0.02% 552
2013
Q3
$177M Sell
2,448,931
-666,175
-21% -$48.1M 0.02% 591
2013
Q2
$174M Buy
+3,115,106
New +$174M 0.02% 576